Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Surgery|December 2, 2023
Factors associated with stoma closure after cytoreductive surgeryMarianna Maspero, Sumeyye Yilmaz, Daniel Joyce, et al.
Gynecologic Oncology|March 11, 2022
Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancerJulia Chalif, Meng Yao, Morgan Gruner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 11, 2026
Interval versus primary cytoreductive surgery in BRCA-mutated advanced-stage ovarian/peritoneal/tubal carcinomaPeter G Rose, Sujata Patil, Meng Yao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 6, 2023
Efficacy and toxicity of carboplatin and gemcitabine administered on day 1 and day 8 (day1&8) versus day 1-only for platinum-sensitive recurrent epithelial ovarian cancerErika J Lampert, Peter G Rose, Meng Yao, et al.
Journal of Gynecology Obstetrics and Human Reproduction|June 27, 2020
Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancerAnthony B Costales, Laura Chambers, Anna Chichura, et al.
Gynecologic Oncology|May 1, 2024
Extended-duration antibiotics are not associated with a reduction in surgical site infection in patients with ovarian cancer undergoing cytoreductive surgery with large bowel resectionJulia Chalif, Laura M Chambers, Meng Yao, et al.
Gynecologic Oncology Reports|November 11, 2021
Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinomaLaura M Chambers, Danielle Chau, Meng Yao, et al.
Gynecologic Oncology|October 5, 2021
Development and validation of a comprehensive clinical risk-scoring model for prediction of overall survival in patients with endometrioid endometrial carcinomaMariam M AlHilli, Lisa Rybicki, Caitlin Carr, et al.
Anti-Cancer Drugs|September 14, 2021
PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancerPeter G Rose, Meng Yao, Laura M Chambers, et al.
NPJ Precision Oncology|August 18, 2025
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancerRoberto Vargas, Aaron Petty, Daniel J Lindner, et al.
Pageof 7